Different RUNX1 translocations have been described in various hematological malignancies, the RUNX1T3/CBFA2T3 fusion being the fifth most frequent partner in cancer-associated RUNX1 rearrangements [121]. This evidence concerns the gene CBFA2T3 and hematologic disorder.